Fasting Glycemia, Glycosylated Hemoglobin and Malnutrition Inflammation Are Associated With Sarcopenia in Older People With Chronic Kidney Disease Undergoing Hemodialysis Treatment: A Cross-Sectional Study
View abstract on PubMed
Summary
This summary is machine-generated.Sarcopenia is common in hemodialysis patients with chronic kidney disease (CKD). Higher fasting blood sugar is linked to increased sarcopenia risk in these older adults.
Area Of Science
- Nephrology
- Geriatrics
- Metabolism
Background
- Conflicting data exist on sarcopenia's association with clinical disorders in hemodialysis patients.
- Sarcopenia is a significant concern in older adults with chronic kidney disease (CKD).
Purpose Of The Study
- To investigate the link between sarcopenia and systemic inflammation, fasting glucose, and quality of life in elderly hemodialysis patients.
- Determine predictors of sarcopenia in this population.
Main Methods
- Cross-sectional study involving individuals over 60 with stage 5 CKD on hemodialysis.
- Sarcopenia assessed using European Working Group criteria.
- Clinical data included BMI, comorbidities, malnutrition-inflammation score, quality of life, glycemic markers, and blood parameters.
Main Results
- Prevalence of sarcopenia was 56.5% among 23 participants.
- Sarcopenic patients had higher fasting glucose, HbA1c, and malnutrition-inflammation scores.
- Significant correlations found between sarcopenia and fasting glucose (r=0.48), HbA1c (r=0.44), and malnutrition-inflammation (r=0.46).
Conclusions
- Sarcopenia is associated with elevated fasting glucose, HbA1c, and malnutrition-inflammation in older hemodialysis patients.
- Fasting glucose emerged as a significant predictor of sarcopenia.
- Further research is needed on glycemic control's impact on sarcopenia in older CKD patients.
Related Concept Videos
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

